Trial · NCT07908901
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment | Up to 3 months from study start | Description: Proportion of the target sample (35) enrolled within 3 months of study start, and the proportion of contacted candidates who provide written consent. Pre-specified progression threshold: at least 80% of target (green). |
| Primary | Retention at week 24 | Week 24 | Proportion of enrolled participants retained at week 24, with reasons for withdrawal or non-progression. Pre-specified progression threshold: at least 75% (green) |
| Primary | Completion of core pathway steps | From enrolment through week 24 | Proportion of enrolled participants completing each core pathway step (pelvic floor screening, gynaecological assessment, documented care plan, pharmacy handover where relevant) and the week-12 and week-24 follow-up. Pre-specified progression threshold: at least 80% (green) |
| Primary | Handovers within target intervals | From questionnaire completion through week 24 | Time in working days between principal pathway steps (questionnaire to pre-screening; pre-screening to pelvic floor screening; pelvic floor screening to gynaecological consultation; prescription to delivery), reported as medians with ranges, and the proportion of handovers completed within target intervals. Pre-specified progression threshold: at least 80% (green). |
| Primary | Participant-rated clarity, coordination and manageability | Week 12 and week 24 | Proportion of participants giving top-2 responses on the study's experience questionnaire items for clarity, coordination and manageability of the pathway. Pre-specified progression threshold: at least 75% (green) |
| Primary | Clinician-rated workflow usability | End of study (after the last participant's week-24 follow-up) | Clinician ratings of the organisation, completeness and usability of the structured symptom report and pathway processes. Pre-specified progression threshold: a clear majority of clinicians rate the workflow usable (green) |
| Primary | Willingness to choose or recommend the pathway | Week 24 | Proportion of participants who would choose or recommend a similar pathway. Pre-specified progression threshold: at least 70% (green) |
| Secondary | Protocol deviations and failed handovers | From enrolment through week 24 | Number and type of protocol deviations, failed handovers and unresolved operational issues. |
| Secondary | Participant experience ratings | Week 12 and week 24 | Distribution of participant ratings for feeling heard, continuity, knowing who to contact, support and practical burden. |
| Secondary | Uptake of optional supportive components | Through week 24 | Number and proportion of participants using the optional videos and psychosexual support, and their perceived relevance. |
| Other | Themes in participant and clinician experience | Week 24 | Thematic analysis of free-text responses and the week-24 participant interview, focusing on coordination, continuity, burden, support and implementation. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07908901/registered